Abstract

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2008 - Hormone Replacement Therapy

Page(s): 355

Download in electronic PDF format for $75
  • Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Page 1

Abstract

A formulation for preparing Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • chloroxylenol
  • chlorhexidine diacetate
  • topical preparations
  • powder
  • skin disorders
  • infection
  • anti-infective agent
  • antibiotic

Related Categories

  • FORMULATIONS
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2008
Pg. 355
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 424
Chlorhexidine Diacetate 2% Topical Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 36-39
The Basics of Compounding Powders and Granules
Author(s): Allen Loyd V Jr
Sep/Oct 2004
Pg. 383
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Nov/Dec 2007
Pg. 507
Chlorhexidine 2% Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Jan/Feb 2017
Pg. 22-27
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Mar/Apr 2008
Pg. 151
Chlorhexidine Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 150-154
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Jul/Aug 2023
Pg. 316
Chlorhexidine and Cetrimide Lotion
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 148
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 515-518
Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L.
Author(s): Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Mar/Apr 2015
Pg. 161-166
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Nov/Dec 2014
Pg. 504-511
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr